Streamlining the HCP engagement process through complianceNOW

Streamlining the HCP engagement process through complianceNOW®

A technology-driven, end-to-end HCP engagement solution

Life sciences companies frequently engage with healthcare professionals (HCPs) to promote their products or therapeutics, provide disease state education and offer overall advisory input. This includes tasks such as selecting key opinion leaders (KOLs), initiating, negotiating and executing contracts, processing payment in accordance with FMV parameters, and ensuring compliance with strict spend transparency reporting requirements. However, these processes are frequently manual and laborious, requiring leaders in life sciences companies to navigate through disjointed systems and coordinate across multiple departments.

Join Baker Tilly for a live walkthrough of our complianceNOW® technology-driven solutions that couples with Baker Tilly’s depth and breadth of healthcare industry experience to create one end-to-end HCP engagement and reporting solution. Throughout the demonstration, we will highlight the functionalities of our complianceNOW suite, encompassing fmvNOW®, kolNOW®, engagementNOW and transparencyNOW; and illustrate how companies can effectively utilize these tools both independently and synergistically. We will specifically focus on how companies can use these tools to:

Evaluate business needs
Enhance their relationships with HCPs through an improved customer experience
Improve internal operational efficiency through streamlining reviews and approvals and achieving a seamless cross-functional alignment
Execute easily pre-engagement compliance controls from HCP selection to FMV determination, tiering and due diligence
Manage all critical engagement execution components
Easily reconcile documentation for payment and performance verification
Adhere to global spend transparency reporting requirements

Who should attend

C-Suite, legal, internal audit, medical affairs, commercial operations and compliance professionals at emerging, mid-tier and large life sciences companies